← All indications
Hyperpigmentation
Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.
Subtype terms (1)
More specific conditions that are subtypes of Hyperpigmentation in the MeSH hierarchy.
- Melanosis
55 drugs (26 approved, 29 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (2)
Phase 2 trials (5)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Other Experimental Indications (9)